找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Squamous Cell Head and Neck Cancer; Recent Clinical Prog David J. Adelstein Book 2005 Humana Press 2005 brachytherapy.cancer.carcinoma.cell

[復(fù)制鏈接]
樓主: 相反
11#
發(fā)表于 2025-3-23 11:01:13 | 只看該作者
12#
發(fā)表于 2025-3-23 13:58:21 | 只看該作者
13#
發(fā)表于 2025-3-23 20:11:57 | 只看該作者
14#
發(fā)表于 2025-3-23 22:29:29 | 只看該作者
15#
發(fā)表于 2025-3-24 03:02:25 | 只看該作者
16#
發(fā)表于 2025-3-24 09:41:31 | 只看該作者
Salvage Surgery After Chemoradiation Therapy,s cell carcinoma (SCC) of the head and neck. This is especially true for SCC of the oropharynx, hypopharynx, and larynx. Primary surgery for advanced T-stage tumors, despite sophisticated reconstruction of the surgical defect, may result in a significant impact on speech, swallowing, and respiration
17#
發(fā)表于 2025-3-24 13:10:55 | 只看該作者
18#
發(fā)表于 2025-3-24 18:31:53 | 只看該作者
Role of Brachytherapy in Treatment of Head and Neck Malignancy,e important in this era of organ preservation and improving quality of life (.,.). There are very few sites in the body where locoregional control is so vital to ultimate quality of life, organ function, and survival as in head and neck cancer. Brachytherapy permits dose intensification specifically
19#
發(fā)表于 2025-3-24 20:18:09 | 只看該作者
Intensity-Modulated Radiation Therapy in the Management of Head and Neck Cancer, are diagnosed each year in the United States, representing 3 to 4% of all cancers (.). Worldwide, head and neck cancer represents a much broader oncology problem (~500,000 annual cases), with tumor development strongly associated with chronic tobacco and alcohol use.
20#
發(fā)表于 2025-3-25 01:26:05 | 只看該作者
Altered Fractionation, manipulation and delivery of cytotoxic agents in conjunction with radiotherapy, there are now new avenues to explore as the classical dose and fraction size limits may no longer apply. Technological developments in physics, computing, and imaging over the past three decades culminated at the end of
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-1 13:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
万安县| 晋中市| 余干县| 民乐县| 抚顺县| 方山县| 达日县| 苗栗县| 京山县| 阜新| 资源县| 盘山县| 旺苍县| 新泰市| 高碑店市| 江陵县| 双鸭山市| 鹿邑县| 枣庄市| 隆尧县| 固始县| 上高县| 铜陵市| 达州市| 喀喇| 夏邑县| 浦县| 厦门市| 项城市| 龙岩市| 桦川县| 乌审旗| 文化| 扶风县| 西藏| 中牟县| 营口市| 钟山县| 珲春市| 永宁县| 长岭县|